Title |
G-protein Coupled Receptor Signaling in Pluripotent Stem Cell-derived Cardiovascular Cells: Implications for Disease Modeling
|
---|---|
Published in |
Frontiers in Cell and Developmental Biology, December 2015
|
DOI | 10.3389/fcell.2015.00076 |
Pubmed ID | |
Authors |
Nazanin F. Dolatshad, Nicola Hellen, Richard J. Jabbour, Sian E. Harding, Gabor Földes |
Abstract |
Human pluripotent stem cell derivatives show promise as an in vitro platform to study a range of human cardiovascular diseases. A better understanding of the biology of stem cells and their cardiovascular derivatives will help to understand the strengths and limitations of this new model system. G-protein coupled receptors (GPCRs) are key regulators of stem cell maintenance and differentiation and have an important role in cardiovascular cell signaling. In this review, we will therefore describe the state of knowledge concerning the regulatory role of GPCRs in both the generation and function of pluripotent stem cell derived-cardiomyocytes, -endothelial, and -vascular smooth muscle cells. We will consider how far the in vitro disease models recapitulate authentic GPCR signaling and provide a useful basis for discovery of disease mechanisms or design of therapeutic strategies. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 4 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 75% |
Scientists | 1 | 25% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 48 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 16 | 33% |
Student > Bachelor | 8 | 17% |
Researcher | 7 | 15% |
Student > Master | 5 | 10% |
Other | 4 | 8% |
Other | 6 | 13% |
Unknown | 2 | 4% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 17 | 35% |
Biochemistry, Genetics and Molecular Biology | 8 | 17% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 8% |
Engineering | 4 | 8% |
Medicine and Dentistry | 3 | 6% |
Other | 7 | 15% |
Unknown | 5 | 10% |